SYNTA PHARMACEUTICALS Trademark

Trademark Overview

On Wednesday, January 12, 2005, a trademark application was filed for SYNTA PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the SYNTA PHARMACEUTICALS trademark a serial number of 76977979. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, September 11, 2015. This trademark is owned by Synta Pharmaceuticals Corp.. The SYNTA PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PRODUCTS, NAMELY, DRUGS FOR INFLAMMATORY DISEASES AND CANCER
synta pharmaceuticals

General Information

Serial Number76977979
Word MarkSYNTA PHARMACEUTICALS
Filing DateWednesday, January 12, 2005
Status800 - REGISTERED AND RENEWED
Status DateFriday, September 11, 2015
Registration Number3125571
Registration DateTuesday, August 8, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2006

Trademark Statements

Disclaimer with Predetermined TextPHARMACEUTICALS
Goods and ServicesPHARMACEUTICAL PRODUCTS, NAMELY, DRUGS FOR INFLAMMATORY DISEASES AND CANCER

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 26, 2005
Primary Code005
First Use Anywhere DateMonday, July 15, 2002
First Use In Commerce DateMonday, July 15, 2002

Trademark Owner History

Party NameSynta Pharmaceuticals Corp.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameSynta Pharmaceuticals Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameSynta Pharmaceuticals Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Thursday, June 2, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 11, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, September 11, 2015REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, September 11, 2015REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, September 11, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, August 12, 2015TEAS SECTION 8 & 9 RECEIVED
Saturday, August 8, 2015COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, February 26, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 26, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, July 26, 2012REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, July 26, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, July 13, 2012TEAS SECTION 8 & 15 RECEIVED
Wednesday, March 26, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 8, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, May 16, 2006PUBLISHED FOR OPPOSITION
Wednesday, April 26, 2006NOTICE OF PUBLICATION
Friday, March 24, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 17, 2006ASSIGNED TO LIE
Thursday, March 16, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 16, 2006USE AMENDMENT ACCEPTED
Thursday, March 16, 2006AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, January 31, 2006USE AMENDMENT FILED
Tuesday, February 14, 2006NOTICE OF DIVIDED TRADEMARK APPLICATION MAILED
Friday, February 10, 2006DIVISIONAL PROCESSING COMPLETE
Tuesday, January 31, 2006DIVISIONAL REQUEST RECEIVED
Tuesday, January 31, 2006PAPER RECEIVED
Wednesday, August 17, 2005NON-FINAL ACTION MAILED
Tuesday, August 16, 2005NON-FINAL ACTION WRITTEN
Friday, August 12, 2005ASSIGNED TO EXAMINER
Wednesday, January 26, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmaceuticals synta diseases cancer inflammatory drugs products namely pharmaceutical